Screener
ADMA Biologics ADMA Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $37.82M+10.5% | $45.33M+68.5% | $49.38M-55.9% | $36.43M+1.4% | $34.22M+6.7% | ||
| $1.7M-15.0% | $1.8M-5.3% | $2M0.0% | $2M+5.3% | $2M+5.3% | ||
| $75K+47.1% | $6.33M+36.9% | $5.39M-0.8% | $5.05M+58.8% | $51K-98.2% | ||
| $29.54M+39.7% | $58.25M+396% | $35.64M-29.0% | $13.29M-46.9% | $21.14M-53.7% | ||
| $2.26M-6.9% | $2.54M-45.9% | $1.08M-60.7% | $14.37M+1,261% | $2.42M+17.2% | ||
| —— | $2.4M+151% | -$276K+90.0% | -$14.37M-1,209% | -$2.53M-6.8% | ||
| $25.05M— | $130.19M— | $8.9M— | $23.04M— | $0— | ||
| -$29.42M— | -$10.13M-42.1% | -$9.12M+70.6% | -$27.83M-9.3% | $0+100% | ||
| —— | $50.52M+260% | —— | -$28.9M— | —— | ||
| $27.28M+45.8% | $55.71M+329% | $34.56M-27.2% | -$1.08M-104% | $18.72M-57.1% |
FAQ
- How much cash does ADMA Biologics generate?
- ADMA Biologics (ADMA) generated $136.7M in operating cash flow over the trailing twelve months.
- What is ADMA Biologics's free cash flow?
- After $20.3M of capital expenditures, ADMA Biologics's free cash flow was $116.5M over the trailing twelve months, up 77.1% year over year.
- Where does ADMA Biologics's cash flow data come from?
- Every line is extracted from ADMA Biologics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
